Please use this identifier to cite or link to this item:
Title: A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis
Authors: Meadows, A
Kaambwa, B
Novielli, N
Huissoon, A
Fry-Smith, A
Meads, C
Barton, P
Dretzke, J
Issue Date: 2013
Publisher: NIHR Health Technology Assessment Programme
Citation: Health Technology Assessment, 17(27), 2013
Abstract: Severe allergic rhinitis uncontrolled by conventional medication can substantially affect quality of life. Immunotherapy involves administering increasing doses of a specific allergen, with the aim of reducing sensitivity and symptomatic reactions. Recent meta-analyses have concluded that both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are more effective than placebo in reducing symptoms. It is uncertain which route of administration is more effective and whether or not treatment is cost-effective.
Description: © Queen’s Printer and Controller of HMSO 2013
ISSN: 1366-5278
Appears in Collections:Biological Sciences
Health Economics Research Group (HERG)
Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf3.07 MBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.